Arcadia Solutions and Boston Children’s Hospital Unveil New Version of Flagship ICU Analytics Product: T3
First Databank (FDB), the leading provider of clinical drug knowledge that improves medication-related decisions and patient outcomes, has announced that medication dosing content is now available for customization in its alert management solution, FDB AlertSpace.
Outcome Engenuity has announced the Just Culture Critical Access Hospital Program. This program will give smaller Critical Access Hospitals better and more ready access to Just Culture materials and training.
PDI, leader in infection prevention education, support and products has launched its new Advanced Skin Antisepsis platform, PDI Prevantics. Under this platform, the company is investing in innovations that provide the most efficient and advanced evidence-based solutions for preventing healthcare associated infections.
Because of their small size, pediatric patients are particularly vulnerable to medication errors. An error that might have minimal effect to an adult could be catastrophic to a child. To help promote awareness of this issue, Medi-Dose/EPS is working with the Emily Jerry Foundation to incorporate their Blue Angel warning logo into MILT 3.0 software.
Despite the best efforts of many, disruptive behavior is still a common and pervasive problem throughout the health care industry. To counteract this, the American College of Physician Executives (ACPE) released a new book to help physician leaders identify and eliminate disruptive behavior.
Awarepoint Corporation, the largest real-time location system (RTLS) corporation dedicated exclusively to healthcare, announces the launch of its new Bed and Bay Sensor that enables precise tracking of mobile equipment and patient and caregiver interactions in locations with tight-bed spacing, such as the emergency department (ED) and pre- and post-anesthesia care.
In an effort to provide the best patient care possible, Western Maryland Health System (WMHS) recently announced its successful integration of B. Braun Medical Inc.'s (B.Braun) innovative Outlook 400ES Safety Infusion System.
It may look like a futuristic gadget from a science fiction movie, but this germ-killing robot is a new, efficient method of tackling hospital superbugs. As reported in the Daily Mail, the device kills hospital superbugs faster than before and could save the NHS $325 million a year if adopted nationwide.
Nearly 2 million people acquire HAIs, or hospital-acquired infections, in the United States each year – resulting in 100,000 deaths annually – according to The Infectious Diseases Society of America. HAIs also lead to more than $4.5 billion in excess healthcare costs, increase the average hospital stay from 4.5 to 20.6 days, and raise the average patient bill from about $30,000 to nearly $200,000, as reported by the U.S. Centers for Disease Control and Prevention.